243 related articles for article (PubMed ID: 22072110)
1. Modulation of renal superoxide dismutase by telmisartan therapy in C57BL/6-Ins2(Akita) diabetic mice.
Fujita H; Fujishima H; Morii T; Sakamoto T; Komatsu K; Hosoba M; Narita T; Takahashi K; Takahashi T; Yamada Y
Hypertens Res; 2012 Feb; 35(2):213-20. PubMed ID: 22072110
[TBL] [Abstract][Full Text] [Related]
2. SOD1, but not SOD3, deficiency accelerates diabetic renal injury in C57BL/6-Ins2(Akita) diabetic mice.
Fujita H; Fujishima H; Takahashi K; Sato T; Shimizu T; Morii T; Shimizu T; Shirasawa T; Qi Z; Breyer MD; Harris RC; Yamada Y; Takahashi T
Metabolism; 2012 Dec; 61(12):1714-24. PubMed ID: 22632894
[TBL] [Abstract][Full Text] [Related]
3. Renoprotective activity of telmisartan versus pioglitazone on ischemia/reperfusion induced renal damage in diabetic rats.
Tawfik MK
Eur Rev Med Pharmacol Sci; 2012 May; 16(5):600-9. PubMed ID: 22774400
[TBL] [Abstract][Full Text] [Related]
4. SGLT2 inhibitor empagliflozin reduces renal growth and albuminuria in proportion to hyperglycemia and prevents glomerular hyperfiltration in diabetic Akita mice.
Vallon V; Gerasimova M; Rose MA; Masuda T; Satriano J; Mayoux E; Koepsell H; Thomson SC; Rieg T
Am J Physiol Renal Physiol; 2014 Jan; 306(2):F194-204. PubMed ID: 24226524
[TBL] [Abstract][Full Text] [Related]
5. Reduction of renal superoxide dismutase in progressive diabetic nephropathy.
Fujita H; Fujishima H; Chida S; Takahashi K; Qi Z; Kanetsuna Y; Breyer MD; Harris RC; Yamada Y; Takahashi T
J Am Soc Nephrol; 2009 Jun; 20(6):1303-13. PubMed ID: 19470681
[TBL] [Abstract][Full Text] [Related]
6. Reduction of Superoxide Dismutase 1 Delays Regeneration of Cardiotoxin-Injured Skeletal Muscle in KK/Ta-
Takahashi Y; Shimizu T; Kato S; Nara M; Suganuma Y; Sato T; Morii T; Yamada Y; Fujita H
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071003
[TBL] [Abstract][Full Text] [Related]
7. An angiotensin II type 1 receptor blocker prevents renal injury via inhibition of the Notch pathway in Ins2 Akita diabetic mice.
Koshizaka M; Takemoto M; Sato S; Tokuyama H; Fujimoto M; Okabe E; Ishibashi R; Ishikawa T; Tsurutani Y; Onishi S; Mezawa M; He P; Honjo S; Ueda S; Saito Y; Yokote K
Exp Diabetes Res; 2012; 2012():159874. PubMed ID: 22319521
[TBL] [Abstract][Full Text] [Related]
8. Effects of stimulation of soluble guanylate cyclase on diabetic nephropathy in diabetic eNOS knockout mice on top of angiotensin II receptor blockade.
Ott IM; Alter ML; von Websky K; Kretschmer A; Tsuprykov O; Sharkovska Y; Krause-Relle K; Raila J; Henze A; Stasch JP; Hocher B
PLoS One; 2012; 7(8):e42623. PubMed ID: 22900035
[TBL] [Abstract][Full Text] [Related]
9. AMPKalpha2 deletion causes aberrant expression and activation of NAD(P)H oxidase and consequent endothelial dysfunction in vivo: role of 26S proteasomes.
Wang S; Zhang M; Liang B; Xu J; Xie Z; Liu C; Viollet B; Yan D; Zou MH
Circ Res; 2010 Apr; 106(6):1117-28. PubMed ID: 20167927
[TBL] [Abstract][Full Text] [Related]
10. Extracellular Superoxide Dismutase Attenuates Renal Oxidative Stress Through the Activation of Adenosine Monophosphate-Activated Protein Kinase in Diabetic Nephropathy.
Hong YA; Lim JH; Kim MY; Kim Y; Park HS; Kim HW; Choi BS; Chang YS; Kim HW; Kim TY; Park CW
Antioxid Redox Signal; 2018 Jun; 28(17):1543-1561. PubMed ID: 29020797
[TBL] [Abstract][Full Text] [Related]
11. Telmisartan attenuates oxidative stress and renal fibrosis in streptozotocin induced diabetic mice with the alteration of angiotensin-(1-7) mas receptor expression associated with its PPAR-γ agonist action.
Lakshmanan AP; Watanabe K; Thandavarayan RA; Sari FR; Harima M; Giridharan VV; Soetikno V; Kodama M; Aizawa Y
Free Radic Res; 2011 May; 45(5):575-84. PubMed ID: 21381899
[TBL] [Abstract][Full Text] [Related]
12. Activation of endothelial NAD(P)H oxidase accelerates early glomerular injury in diabetic mice.
Nagasu H; Satoh M; Kiyokage E; Kidokoro K; Toida K; Channon KM; Kanwar YS; Sasaki T; Kashihara N
Lab Invest; 2016 Jan; 96(1):25-36. PubMed ID: 26552047
[TBL] [Abstract][Full Text] [Related]
13. Reduction of circulating superoxide dismutase activity in type 2 diabetic patients with microalbuminuria and its modulation by telmisartan therapy.
Fujita H; Sakamoto T; Komatsu K; Fujishima H; Morii T; Narita T; Takahashi T; Yamada Y
Hypertens Res; 2011 Dec; 34(12):1302-8. PubMed ID: 21814206
[TBL] [Abstract][Full Text] [Related]
14. Deletion of p47phox attenuates the progression of diabetic nephropathy and reduces the severity of diabetes in the Akita mouse.
Liu GC; Fang F; Zhou J; Koulajian K; Yang S; Lam L; Reich HN; John R; Herzenberg AM; Giacca A; Oudit GY; Scholey JW
Diabetologia; 2012 Sep; 55(9):2522-32. PubMed ID: 22653270
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin II type 1 receptor blocker telmisartan suppresses superoxide production and reduces atherosclerotic lesion formation in apolipoprotein E-deficient mice.
Takaya T; Kawashima S; Shinohara M; Yamashita T; Toh R; Sasaki N; Inoue N; Hirata K; Yokoyama M
Atherosclerosis; 2006 Jun; 186(2):402-10. PubMed ID: 16157344
[TBL] [Abstract][Full Text] [Related]
16. Telmisartan attenuates fatty-acid-induced oxidative stress and NAD(P)H oxidase activity in pancreatic beta-cells.
Saitoh Y; Hongwei W; Ueno H; Mizuta M; Nakazato M
Diabetes Metab; 2009 Nov; 35(5):392-7. PubMed ID: 19713141
[TBL] [Abstract][Full Text] [Related]
17. Administration of telmisartan reduced systolic blood pressure and oxidative stress probably through the activation of PI3K/Akt/eNOS pathway and NO release in spontaneously hypertensive rats.
Xu L; Liu Y
Physiol Res; 2013; 62(4):351-9. PubMed ID: 23590610
[TBL] [Abstract][Full Text] [Related]
18. High-cholesterol diet augments endothelial dysfunction via elevated oxidative stress and reduced tetrahydrobiopterin in Ins2(Akita) mice, an autosomal dominant mutant type 1 diabetic model.
Yang XQ; Chen AF
Clin Exp Pharmacol Physiol; 2009 Aug; 36(8):764-9. PubMed ID: 19207718
[TBL] [Abstract][Full Text] [Related]
19. The combined strategy with PPARα agonism and AT₁ receptor antagonism is not superior relative to their individual treatment approach in preventing the induction of nephropathy in the diabetic rat.
Bishnoi HK; Mahadevan N; Balakumar P
Pharmacol Res; 2012 Oct; 66(4):349-56. PubMed ID: 22796657
[TBL] [Abstract][Full Text] [Related]
20. AT1-receptor blockade by telmisartan upregulates GTP-cyclohydrolase I and protects eNOS in diabetic rats.
Wenzel P; Schulz E; Oelze M; Müller J; Schuhmacher S; Alhamdani MS; Debrezion J; Hortmann M; Reifenberg K; Fleming I; Münzel T; Daiber A
Free Radic Biol Med; 2008 Sep; 45(5):619-26. PubMed ID: 18539157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
